The cutting edge: Membrane-anchored serine protease activities in the pericellular microenvironment

Biochemical Journal

Volumn 428, Issue 3, 2010, Pages 325-346

  Antalis, Toni M ^a   Buzza, Marguerite S ^a   Hodge, Kathryn M ^a   Hooper, John D ^b   Netzel Arnett, Sarah ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Membrane serine protease; Pericellular proteolysis; Serine protease inhibitor; Type II transmembrane serine protease (TTSP)

Indexed keywords

PERICELLULAR PROTEOLYSIS; SERINE PROTEASE; SERINE PROTEASE INHIBITOR; TRANSMEMBRANES; TYPE II;

CELL MEMBRANES; COAGULATION; DISEASES; ENZYME ACTIVITY; HORMONES; MACHINERY; MAMMALS; MEMBRANES; PEPTIDES; PHOSPHATASES; PHYSIOLOGICAL MODELS; PHYSIOLOGY;

AMINO ACIDS;

ATRIAL NATRIURETIC FACTOR; ENZYME PRECURSOR; EPITHELIAL SODIUM CHANNEL; GROWTH FACTOR; HEPSIN; IRON; MATRIPTASE; PROSTASIN; PROTEINASE ACTIVATED RECEPTOR; SERINE PROTEINASE; VIRUS PROTEIN;

CATALYSIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SUBSTRATE; HOMEOSTASIS; IN VITRO STUDY; IN VIVO STUDY; MUTATION; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROCESSING; PROTEIN DEGRADATION; REVIEW; TUMOR MICROENVIRONMENT; ANIMAL; CELL MEMBRANE; ENZYME SPECIFICITY; ENZYMOLOGY; HUMAN; METABOLISM;

ANIMALIA; MAMMALIA;

ANIMALS; CELL MEMBRANE; HUMANS; SERINE PROTEASES; SUBSTRATE SPECIFICITY;

EID: 77954915960     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20100046     Document Type: Review

References (240)

1. Ramsay, A. J., Quesada, V., Sanchez, M., Garabaya, C., Sarda, M. P., Baiget, M., Remacha, A., Velasco, G. and Lopez-Otin, C. (2009) Matriptase-2 mutations in iron-refractory iron deficiency anemia patients provide new insights into protease activation mechanisms. Hum. Mol. Genet. 18, 3673-3683
2. Neurath, H. and Walsh, K. A. (1976) Role of proteolytic enzymes in biological regulation (a review). Proc. Natl. Acad. Sci. U.S.A. 73, 3825-3832
3. Hedstrom, L. (2002) Serine protease mechanism and specificity. Chem. Rev. 102, 4501-4524
4. Rawlings, N. D. and Barrett, A. J. (2004) Introduction: serine peptidases and their clans. In Handbook of Proteolytic Enzymes, 2nd edn, vol. 2 (Barrett, A. J., Rawlings, N. D. and Woessner, J. F., eds), pp. 1417-1439, Elsevier, London
5. Rawlings, N. D., Morton, F. R., Kok, C. Y., Kong, J. and Barrett, A. J. (2008) MEROPS: the peptidase database. Nucleic Acids Res. 36, D320-D325
6. Rawlings, N. D. and Morton, F. R. (2008) The MEROPS batch BLAST: a tool to detect peptidases and their non-peptidase homologues in a genome. Biochimie 90, 243-259
7. Plow, E. F. and Miles, L. A. (1990) Plasminogen receptors in the mediation of pericellular proteolysis. Cell Differ. Dev. 32, 293-298
8. Hooper, J. D., Clements, J. A., Quigley, J. P. and Antalis, T. M. (2001) Type II transmembrane serine proteases. Insights into an emerging class of cell surface proteolytic enzymes. J. Biol. Chem. 276, 857-860
9. Netzel-Arnett, S., Hooper, J. D., Szabo, R., Madison, E. L., Quigley, J. P., Bugge, T. H. and Antalis, T. M. (2003) Membrane anchored serine proteases: a rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer. Cancer Metastasis Rev. 22, 237-258
10. Szabo, R. and Bugge, T. H. (2008) Type II transmembrane serine proteases in development and disease. Int. J. Biochem. Cell Biol. 40, 1297-1316
11. Puente, X. S., Sanchez, L. M., Overall, C. M. and Lopez-Otin, C. (2003) Human and mouse proteases: a comparative genomic approach. Nat. Rev. Genet. 4, 544-558
12. Bugge, T. H., Antalis, T. M. and Wu, Q. (2009) Type II transmembrane serine proteases. J. Biol. Chem. 284, 23177-23181
13. Caughey, G. H., Raymond, W. W., Blount, J. L., Hau, L. W., Pallaoro, M., Wolters, P. J. and Verghese, G. M. (2000) Characterization of human gamma-tryptases, novel members of the chromosome 16p mast cell tryptase and prostasin gene families. J. Immunol. 164, 6566-6575 (Pubitemid 30408843)
14. Wong, G. W., Tang, Y., Feyfant, E., Sali, A., Li, L., Li, Y., Huang, C., Friend, D. S., Krilis, S. A. and Stevens, R. L. (1999) Identification of a new member of the tryptase family of mouse and human mast cell proteases which possesses a novel COOH-terminal hydrophobic extension. J. Biol. Chem. 274, 30784-30793
15. Yu, J. X., Chao, L. and Chao, J. (1994) Prostasin is a novel human serine proteinase from seminal fluid. Purification, tissue distribution, and localization in prostate gland. J. Biol. Chem. 269, 18843-18848
16. Chen, L. M., Skinner, M. L., Kauffman, S. W., Chao, J., Chao, L., Thaler, C. D. and Chai, K. X. (2001) Prostasin is a glycosylphosphatidylinositol- anchored active serine protease. J. Biol. Chem. 276, 21434-21442
17. Verghese, G. M., Gutknecht, M. F. and Caughey, G. H. (2006) Prostasin regulates epithelial monolayer function: cell-specific Gpld1-mediated secretion and functional role for GPI anchor. Am. J. Physiol. Cell Physiol. 291, C1258-C1270
18. Honda, A., Yamagata, K., Sugiura, S., Watanabe, K. and Baba, T. (2002) A mouse serine protease TESP5 is selectively included into lipid rafts of sperm membrane presumably as a glycosylphosphatidylinositol-anchored protein. J. Biol. Chem. 277, 16976-16984
19. Hooper, J. D., Nicol, D. L., Dickinson, J. L., Eyre, H. J., Scarman, A. L., Normyle, J. F., Stuttgen, M. A., Douglas, M. L., Loveland, K. A., Sutherland, G. R. and Antalis, T. M. (1999) Testisin, a new human serine proteinase expressed by premeiotic testicular germ cells and lost in testicular germ cell tumors. Cancer Res. 59, 3199-3205
20. Kitamoto, Y., Yuan, X., Wu, Q., McCourt, D. W. and Sadler, J. E. (1994) Enterokinase, the initiator of intestinal digestion, is a mosaic protease composed of a distinctive assortment of domains. Proc. Natl. Acad. Sci. U.S.A. 91, 7588-7592
21. Szabo, R., Wu, Q., Dickson, R. B., Netzel-Arnett, S., Antalis, T. M. and Bugge, T. H. (2003) Type II transmembrane serine proteases. Thromb. Haemostasis 90, 185-193
22. Cal, S., Quesada, V., Garabaya, C. and Lopez-Otin, C. (2003) Polyserase-I, a human polyprotease with the ability to generate independent serine protease domains from a single translation product. Proc. Natl. Acad. Sci. U.S.A. 100, 9185-9190
23. Okumura, Y., Hayama, M., Takahashi, E., Fujiuchi, M., Shimabukuro, A., Yano, M. and Kido, H. (2006) Serase-1B, a new splice variant of polyserase-1/TMPRSS9, activates urokinase-type plasminogen activator and the proteolytic activation is negatively regulated by glycosaminoglycans. Biochem. J. 400, 551-561
24. Hansen, I. A., Fassnacht, M., Hahner, S., Hammer, F., Schammann, M., Meyer, S. R., Bicknell, A. B. and Allolio, B. (2004) The adrenal secretory serine protease AsP is a short secretory isoform of the transmembrane airway trypsin-like protease. Endocrinology 145, 1898-1905
25. Bhagwandin, V. J., Hau, L. W., Mallen-St Clair, J., Wolters, P. J. and Caughey, G. H. (2003) Structure and activity of human pancreasin, a novel tryptic serine peptidase expressed primarily by the pancreas. J. Biol. Chem. 278, 3363-3371
26. Wong, G. W., Foster, P. S., Yasuda, S., Qi, J. C., Mahalingam, S., Mellor, E. A., Katsoulotos, G., Li, L., Boyce, J. A., Krilis, S. A. and Stevens, R. L. (2002) Biochemical and functional characterization of human transmembrane tryptase (TMT)/tryptase gamma. TMT is an exocytosed mast cell protease that induces airway hyperresponsiveness in vivo via an interleukin-13/interleukin-4 receptor alpha/signal transducer and activator of transcription (STAT) 6-dependent pathway. J. Biol. Chem. 277, 41906-41915
27. Tsuzuki, S., Murai, N., Miyake, Y., Inouye, K., Hirayasu, H., Iwanaga, T. and Fushiki, T. (2005) Evidence for the occurrence of membrane-type serine protease 1/matriptase on the basolateral sides of enterocytes. Biochem. J. 388, 679-687
28. Wang, J. K., Lee, M. S., Tseng, I. C., Chou, F. P., Chen, Y. W., Fulton, A., Lee, H. S., Chen, C. J., Johnson, M. D. and Lin, C. Y. (2009) Polarized epithelial cells secrete matriptase as a consequence of zymogen activation and HAI-1-mediated inhibition. Am. J. Physiol. Cell Physiol. 297, C459-C470
29. Buzza, M. S., Netzel-Arnett, S., Shea-Donohue, T., Zhao, A., Lin, C. Y., List, K., Szabo, R., Fasano, A., Bugge, T. H. and Antalis, T. M. (2010) Membrane-anchored serine protease matriptase regulates epithelial barrier formation and permeability in the intestine. Proc. Natl. Acad. Sci. U.S.A. 107, 4200-4205
30. Hung, R. J., Hsu, I., Dreiling, J. L., Lee, M. J., Williams, C. A., Oberst, M. D., Dickson, R. B. and Lin, C. Y. (2004) Assembly of adherens junctions is required for sphingosine 1-phosphate-induced matriptase accumulation and activation at mammary epithelial cell-cell contacts. Am. J. Physiol. Cell Physiol. 286, C1159-C1169
31. Murai, N., Miyake, Y., Tsuzuki, S., Inouye, K. and Fushiki, T. (2009) Involvement of the cytoplasmic juxtamembrane region of matriptase in its exclusive localization to the basolateral membrane domain of Madin-Darby canine kidney epithelial cells. Cytotechnology 59, 169-176
32. Kim, C., Cho, Y., Kang, C. H., Kim, M. G., Lee, H., Cho, E. G. and Park, D. (2005) Filamin is essential for shedding of the transmembrane serine protease, epithin. EMBO Rep. 6, 1045-1051
33. Miao, J., Mu, D., Ergel, B., Singavarapu, R., Duan, Z., Powers, S., Oliva, E. and Orsulic, S. (2008) Hepsin colocalizes with desmosomes and induces progression of ovarian cancer in a mouse model. Int. J. Cancer 123, 2041-2047
34. Vallet, V., Chraibi, A., Gaeggeler, H. P., Horisberger, J. D. and Rossier, B. C. (1997) An epithelial serine protease activates the amiloride-sensitive sodium channel. Nature 389, 607-610
35. Selzer-Plon, J., Bornholdt, J., Friis, S., Bisgaard, H. C., Lothe, I. M., Tveit, K. M., Kure, E. H., Vogel, U. and Vogel, L. K. (2009) Expression of prostasin and its inhibitors during colorectal cancer carcinogenesis. BMC Cancer 9, 201
36. Jacquinet, E., Rao, N. V., Rao, G. V. and Hoidal, J. R. (2000) Cloning, genomic organization, chromosomal assignment and expression of a novel mosaic serine proteinase: epitheliasin. FEBS Lett. 468, 93-100
37. Afar, D. E., Vivanco, I., Hubert, R. S., Kuo, J., Chen, E., Saffran, D. C., Raitano, A. B. and Jakobovits, A. (2001) Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia. Cancer Res. 61, 1686-1692
38. Zheng, X., Lu, D. and Sadler, J. E. (1999) Apical sorting of bovine enteropeptidase does not involve detergent- resistant association with sphingolipid-cholesterol rafts. J. Biol. Chem. 274, 1596-1605
39. Zheng, X. and Sadler, J. E. (2002) Mucin-like domain of enteropeptidase directs apical targeting in Madin-Darby canine kidney cells. J. Biol. Chem. 277, 6858-6863
40. Guipponi, M., Toh, M. Y., Tan, J., Park, D., Hanson, K., Ballana, E., Kwong, D., Cannon, P. Z., Wu, Q., Gout, A. et al. (2008) An integrated genetic and functional analysis of the role of type II transmembrane serine proteases (TMPRSSs) in hearing loss. Hum. Mutat. 29, 130-141
41. Lucas, J. M., True, L., Hawley, S., Matsumura, M., Morrissey, C., Vessella, R. and Nelson, P. S. (2008) The androgen-regulated type II serine protease TMPRSS2 is differentially expressed and mislocalized in prostate adenocarcinoma. J. Pathol. 215, 118-125
42. Koda, A., Wakida, N., Toriyama, K., Yamamoto, K., Iijima, H., Tomita, K. and Kitamura, K. (2009) Urinary prostasin in humans: relationships among prostasin, aldosterone and epithelial sodium channel activity. Hypertens. Res. 32, 276-281
43. Zhu, H., Chao, J., Guo, D., Li, K., Huang, Y., Hawkins, K., Wright, N., Stallmann-Jorgensen, I., Yan, W., Harshfield, G. A. and Dong, Y. (2009) Urinary prostasin: a possible biomarker for renal pressure natriuresis in black adolescents. Pediatr. Res. 65, 443-446
44. Olivieri, O., Castagna, A., Guarini, P., Chiecchi, L., Sabaini, G., Pizzolo, F., Corrocher, R. and Righetti, P. G. (2005) Urinary prostasin: a candidate marker of epithelial sodium channel activation in humans. Hypertension 46, 683-688
45. Narikiyo, T., Kitamura, K., Adachi, M., Miyoshi, T., Iwashita, K., Shiraishi, N., Nonoguchi, H., Chen, L. M., Chai, K. X., Chao, J. and Tomita, K. (2002) Regulation of prostasin by aldosterone in the kidney. J. Clin. Invest. 109, 401-408
46. Iwashita, K., Kitamura, K., Narikiyo, T., Adachi, M., Shiraishi, N., Miyoshi, T., Nagano, J., Tuyen, D. G., Nonoguchi, H. and Tomita, K. (2003) Inhibition of prostasin secretion by serine protease inhibitors in the kidney. J. Am. Soc. Nephrol. 14, 11-16
47. Lin, C. Y., Anders, J., Johnson, M. and Dickson, R. B. (1999) Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk. J. Biol. Chem. 274, 18237-18242
48. Shi, Y. E., Torri, J., Yieh, L., Wellstein, A., Lippman, M. E. and Dickson, R. B. (1993) Identification and characterization of a novel matrix-degrading protease from hormone-dependent human breast cancer cells. Cancer Res. 53, 1409-1415 (Pubitemid 23097125)
49. Cho, E. G., Kim, M. G., Kim, C., Kim, S. R., Seong, I. S., Chung, C., Schwartz, R. H. and Park, D. (2001) N-terminal processing is essential for release of epithin, a mouse type II membrane serine protease. J. Biol. Chem. 276, 44581-44589
50. Benaud, C., Dickson, R. B. and Lin, C. Y. (2001) Regulation of the activity of matriptase on epithelial cell surfaces by a blood-derived factor. Eur. J. Biochem. 268, 1439-1447
51. Jin, X., Hirosaki, T., Lin, C. Y., Dickson, R. B., Higashi, S., Kitamura, H. and Miyazaki, K. (2005) Production of soluble matriptase by human cancer cell lines and cell surface activation of its zymogen by trypsin. J. Cell Biochem. 95, 632-647
52. Moss, S., Birch, G. R., Lobley, R. W. and Holmes, R. (1979) The release of enterokinase following secretin and cholecystokinin-pancreozymin in man. Scand. J. Gastroenterol. 14, 1001-1007
53. Lebenthal, E. and Lee, P. C. (1982) Effect of pancreozymin and secretin on intraluminal enterokinase, trypsin, and chymotrypsin activities of cystic fibrosis and control children. Digestion 23, 39-47
54. Yasuoka, S., Ohnishi, T., Kawano, S., Tsuchihashi, S., Ogawara, M., Masuda, K., Yamaoka, K., Takahashi, M. and Sano, T. (1997) Purification, characterization, and localization of a novel trypsin- like protease found in the human airway. Am. J. Respir. Cell Mol. Biol. 16, 300-308
55. Matsushima, M., Ichinose, M., Yahagi, N., Kakei, N., Tsukada, S., Miki, K., Kurokawa, K., Tashiro, K., Shiokawa, K., Shinomiya, K. et al. (1994) Structural characterization of porcine enteropeptidase. J. Biol. Chem. 269, 19976-19982
56. Cho, E. G., Schwartz, R. H. and Kim, M. G. (2005) Shedding of membrane epithin is blocked without LDLRA4 and its protease activation site. Biochem. Biophys. Res. Commun. 327, 328-334
57. Schechter, I. and Berger, A. (1967) On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 27, 157-162
58. Friedrich, R., Fuentes-Prior, P., Ong, E., Coombs, G., Hunter, M., Oehler, R., Pierson, D., Gonzalez, R., Huber, R., Bode, W. and Madison, E. L. (2002) Catalytic domain structures of MT-SP1/matriptase, a matrix-degrading transmembrane serine proteinase. J. Biol. Chem. 277, 2160-2168
59. Somoza, J. R., Ho, J. D., Luong, C., Ghate, M., Sprengeler, P. A., Mortara, K., Shrader, W. D., Sperandio, D., Chan, H., McGrath, M. E. and Katz, B. A. (2003) The structure of the extracellular region of human hepsin reveals a serine protease domain and a novel scavenger receptor cysteine-rich (SRCR) domain. Structure 11, 1123-1131
60. Lu, D., Futterer, K., Korolev, S., Zheng, X., Tan, K., Waksman, G. and Sadler, J. E. (1999) Crystal structure of enteropeptidase light chain complexed with an analog of the trypsinogen activation peptide. J. Mol. Biol. 292, 361-373
61. Kyrieleis, O. J., Huber, R., Ong, E., Oehler, R., Hunter, M., Madison, E. L. and Jacob, U. (2007) Crystal structure of the catalytic domain of DESC1, a new member of the type II transmembrane serine proteinase family. FEBS J. 274, 2148-2160
62. Spraggon, G., Hornsby, M., Shipway, A., Tully, D. C., Bursulaya, B., Danahay, H., Harris, J. L. and Lesley, S. A. (2009) Active site conformational changes of prostasin provide a new mechanism of protease regulation by divalent cations. Protein Sci. 18, 1081-1094
63. Tully, D. C., Vidal, A., Chatterjee, A. K., Williams, J. A., Roberts, M. J., Petrassi, H. M., Spraggon, G., Bursulaya, B., Pacoma, R., Shipway, A. et al. (2008) Discovery of inhibitors of the channel-activating protease prostasin (CAP1/PRSS8) utilizing structure-based design. Bioorg. Med. Chem. Lett. 18, 5895-5899
64. Rickert, K. W., Kelley, P., Byrne, N. J., Diehl, R. E., Hall, D. L., Montalvo, A. M., Reid, J. C., Shipman, J. M., Thomas, B. W., Munshi, S. K. et al. (2008) Structure of human prostasin, a target for the regulation of hypertension. J. Biol. Chem. 283, 34864-34872
65. Friedrich, R., Steinmetzer, T., Huber, R., Sturzebecher, J. and Bode, W. (2002) The methyl group of Nα(Me)Arg-containing peptides disturbs the active-site geometry of thrombin, impairing efficient cleavage. J. Mol. Biol. 316, 869-874
66. Oberst, M. D., Williams, C. A., Dickson, R. B., Johnson, M. D. and Lin, C. Y. (2003) The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitor. J. Biol. Chem. 278, 26773-26779
67. Lin, C. Y., Tseng, I. C., Chou, F. P., Su, S. F., Chen, Y. W., Johnson, M. D. and Dickson, R. B. (2008) Zymogen activation, inhibition, and ectodomain shedding of matriptase. Front. Biosci. 13, 621-635
68. Macao, B., Johansson, D. G., Hansson, G. C. and Hard, T. (2006) Autoproteolysis coupled to protein folding in the SEA domain of the membrane-bound MUC1 mucin. Nat. Struct. Mol. Biol. 13, 71-76
69. Lee, M. S., Tseng, I. C., Wang, Y., Kiyomiya, K., Johnson, M. D., Dickson, R. B. and Lin, C. Y. (2007) Autoactivation of matriptase in vitro: requirement for biomembrane and LDL receptor domain. Am. J. Physiol. Cell Physiol. 293, C95-C105
70. Knappe, S., Wu, F., Madlansacay, M. R. and Wu, Q. (2004) Identification of domain structures in the propeptide of corin essential for the processing of proatrial natriuretic peptide. J. Biol. Chem. 279, 34464-34471
71. Lu, D., Yuan, X., Zheng, X. and Sadler, J. E. (1997) Bovine proenteropeptidase is activated by trypsin, and the specificity of enteropeptidase depends on the heavy chain. J. Biol. Chem. 272, 31293-31300
72. Gladysheva, I. P., King, S. M. and Houng, A. K. (2008) N-glycosylation modulates the cell-surface expression and catalytic activity of corin. Biochem. Biophys. Res. Commun. 373, 130-135
73. Liao, X., Wang, W., Chen, S. and Wu, Q. (2007) Role of glycosylation in corin zymogen activation. J. Biol. Chem. 282, 27728-27735
74. Ramsay, A. J., Reid, J. C., Velasco, G., Quigley, J. P. and Hooper, J. D. (2008) The type II transmembrane serine protease matriptase-2-identification, structural features, enzymology, expression pattern and potential roles. Front. Biosci. 13, 569-579
75. Silvestri, L., Guillem, F., Pagani, A., Nai, A., Oudin, C., Silva, M., Toutain, F., Kannengiesser, C., Beaumont, C., Camaschella, C. and Grandchamp, B. (2009) Molecular mechanisms of the defective hepcidin inhibition in TMPRSS6 mutations associated with iron-refractory iron deficiency anemia. Blood 113, 5605-5608
76. Tchou, I., Diepold, M., Pilotto, P. A., Swinkels, D., Neerman-Arbez, M. and Beris, P. (2009) Haematologic data, iron parameters and molecular findings in two new cases of iron-refractory iron deficiency anaemia. Eur. J. Haematol. 83, 595-602
77. Rame, J. E., Drazner, M. H., Post, W., Peshock, R., Lima, J., Cooper, R. S. and Dries, D. L. (2007) Corin I555(P568) allele is associated with enhanced cardiac hypertrophic response to increased systemic afterload. Hypertension 49, 857-864
78. Dries, D. L., Victor, R. G., Rame, J. E., Cooper, R. S., Wu, X., Zhu, X., Leonard, D., Ho, S. I., Wu, Q., Post, W. and Drazner, M. H. (2005) Corin gene minor allele defined by 2 missense mutations is common in blacks and associated with high blood pressure and hypertension. Circulation 112, 2403-2410
79. Wang, W., Liao, X., Fukuda, K., Knappe, S., Wu, F., Dries, D. L., Qin, J. and Wu, Q. (2008) Corin variant associated with hypertension and cardiac hypertrophy exhibits impaired zymogen activation and natriuretic peptide processing activity. Circ. Res. 103, 502-508
80. Guipponi, M., Vuagniaux, G., Wattenhofer, M., Shibuya, K., Vazquez, M., Dougherty, L., Scamuffa, N., Guida, E., Okui, M., Rossier, C. et al. (2002) The transmembrane serine protease (TMPRSS3) mutated in deafness DFNB8/10 activates the epithelial sodium channel (ENaC) in vitro. Hum. Mol. Genet. 11, 2829-2836
81. Takeuchi, T., Harris, J. L., Huang, W., Yan, K. W., Coughlin, S. R. and Craik, C. S. (2000) Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates. J. Biol. Chem. 275, 26333-26342
82. Boulware, K. T. and Daugherty, P. S. (2006) Protease specificity determination by using cellular libraries of peptide substrates (CLiPS). Proc. Natl. Acad. Sci. U.S.A. 103, 7583-7588
83. Herter, S., Piper, D. E., Aaron, W., Gabriele, T., Cutler, G., Cao, P., Bhatt, A. S., Choe, Y., Craik, C. S., Walker, N. et al. (2005) Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers. Biochem. J. 390, 125-136
84. Kido, H. and Okumura, Y. (2008) MSPL/TMPRSS13. Front. Biosci. 13, 754-758
85. Shipway, A., Danahay, H., Williams, J. A., Tully, D. C., Backes, B. J. and Harris, J. L. (2004) Biochemical characterization of prostasin, a channel activating protease. Biochem. Biophys. Res. Commun. 324, 953-963
86. Hobson, J. P., Netzel-Arnett, S., Szabo, R., Rehault, S. M., Church, F. C., Strickland, D. K., Lawrence, D. A., Antalis, T. M. and Bugge, T. H. (2004) Mouse DESC1 is located within a cluster of seven DESC1-like genes and encodes a type II transmembrane serine protease that forms serpin inhibitory complexes. J. Biol. Chem. 279, 46981-46994
87. Beliveau, F., Desilets, A. and Leduc, R. (2009) Probing the substrate specificities of matriptase, matriptase-2, hepsin and DESC1 with internally quenched fluorescent peptides. FEBS J. 276, 2213-2226
88. Antalis, T. M., Shea-Donohue, T., Vogel, S. N., Sears, C. and Fasano, A. (2007) Mechanisms of disease: protease functions in intestinal mucosal pathobiology. Nat. Clin. Pract. Gastroenterol. Hepatol. 4, 393-402
89. Neurath, H. (1985) Proteolytic enzymes, past and present. Fed. Proc. 44, 2907-2913
90. Holzinger, A., Maier, E. M., Buck, C., Mayerhofer, P. U., Kappler, M., Haworth, J. C., Moroz, S. P., Hadorn, H. B., Sadler, J. E. and Roscher, A. A. (2002) Mutations in the proenteropeptidase gene are the molecular cause of congenital enteropeptidase deficiency. Am. J. Hum. Genet. 70, 20-25
91. Kazama, Y., Hamamoto, T., Foster, D. C. and Kisiel, W. (1995) Hepsin, a putative membrane-associated serine protease, activates human factor VII and initiates a pathway of blood coagulation on the cell surface leading to thrombin formation. J. Biol. Chem. 270, 66-72
92. Cao, C., Lawrence, D. A., Li, Y., Von Arnim, C. A., Herz, J., Su, E. J., Makarova, A., Hyman, B. T., Strickland, D. K. and Zhang, L. (2006) Endocytic receptor LRP together with tPA and PAI-1 coordinates Mac-1-dependent macrophage migration. EMBO J. 25, 1860-1870
93. Moran, P., Li, W., Fan, B., Vij, R., Eigenbrot, C. and Kirchhofer, D. (2006) Pro-urokinase-type plasminogen activator is a substrate for hepsin. J. Biol. Chem. 281, 30439-30446
94. Lee, S. L., Dickson, R. B. and Lin, C. Y. (2000) Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease. J. Biol. Chem. 275, 36720-36725
95. Kilpatrick, L. M., Harris, R. L., Owen, K. A., Bass, R., Ghorayeb, C., Bar-Or, A. and Ellis, V. (2006) Initiation of plasminogen activation on the surface of monocytes expressing the type II transmembrane serine protease matriptase. Blood 108, 2616-2623
96. Beaufort, N., Leduc, D., Eguchi, H., Mengele, K., Hellmann, D., Masegi, T., Kamimura, T., Yasuoka, S., Fend, F., Chignard, M. and Pidard, D. (2007) The human airway trypsin-like protease modulates the urokinase receptor (uPAR, CD87) structure and functions. Am. J. Physiol. Lung Cell. Mol. Physiol. 292, L1263-L1272
97. Preissner, K. T., Kanse, S. M. and May, A. E. (2000) Urokinase receptor: a molecular organizer in cellular communication. Curr. Opin. Cell Biol. 12, 621-628
98. Jin, X., Yagi, M., Akiyama, N., Hirosaki, T., Higashi, S., Lin, C. Y., Dickson, R. B., Kitamura, H. and Miyazaki, K. (2006) Matriptase activates stromelysin (MMP-3) and promotes tumor growth and angiogenesis. Cancer Sci. 97, 1327-1334 (Pubitemid 44614984)
99. Netzel-Arnett, S., Currie, B. M., Szabo, R., Lin, C. Y., Chen, L. M., Chai, K. X., Antalis, T. M., Bugge, T. H. and List, K. (2006) Evidence for a matriptase-prostasin proteolytic cascade regulating terminal epidermal differentiation. J. Biol. Chem. 281, 32941-32945
100. Camerer, E., Barker, A., Duong, D. N., Ganesan, R., Kataoka, H., Cornelissen, I., Darragh, M. R., Hussain, A., Zheng, Y. W., Srinivasan, Y. et al. (2010) Local protease signaling contributes to neural tube closure in the mouse embryo. Dev. Cell 18, 25-38
101. Vu, T. K., Liu, R. W., Haaksma, C. J., Tomasek, J. J. and Howard, E. W. (1997) Identification and cloning of the membrane-associated serine protease, hepsin, from mouse preimplantation embryos. J. Biol. Chem. 272, 31315-31320
102. Stallmach, R. and Gloor, S. M. (2008) Neurobin/TMPRSS11c, a novel type II transmembrane serine protease that cleaves fibroblast growth factor-2 in vitro. Biochem. J. 412, 81-91
103. Desilets, A., Beliveau, F., Vandal, G., McDuff, F. O., Lavigne, P. and Leduc, R. (2008) Mutation G827R in matriptase causing autosomal recessive ichthyosis with hypotrichosis yields an inactive protease. J. Biol. Chem. 283, 10535-10542
104. Velasco, G., Cal, S., Quesada, V., Sanchez, L. M. and Lopez-Otin, C. (2002) Matriptase-2, a membrane-bound mosaic serine proteinase predominantly expressed in human liver and showing degrading activity against extracellular matrix proteins. J. Biol. Chem. 277, 37637-37646
105. Qiu, D., Owen, K., Gray, K., Bass, R. and Ellis, V. (2007) Roles and regulation of membrane-associated serine proteases. Biochem. Soc. Trans. 35, 583-587
106. Andreasen, D., Vuagniaux, G., Fowler-Jaeger, N., Hummler, E. and Rossier, B. C. (2006) Activation of epithelial sodium channels by mouse channel activating proteases (mCAP) expressed in Xenopus oocytes requires catalytic activity of mCAP3 and mCAP2 but not mCAP1. J. Am. Soc. Nephrol. 17, 968-976
107. Coughlin, S. R. (1999) How the protease thrombin talks to cells. Proc. Natl. Acad. Sci. U.S.A. 96, 11023-11027
108. Arora, P., Ricks, T. K. and Trejo, J. (2007) Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer. J. Cell Sci. 120, 921-928
109. Ossovskaya, V. S. and Bunnett, N. W. (2004) Protease-activated receptors: contribution to physiology and disease. Physiol Rev. 84, 579-621
110. Cottrell, G. S., Amadesi, S., Schmidlin, F. and Bunnett, N. (2003) Protease-activated receptor 2: activation, signalling and function. Biochem. Soc.Trans. 31, 1191-1197
111. Ramsay, A. J., Reid, J. C., Adams, M. N., Samaratunga, H., Dong, Y., Clements, J. A. and Hooper, J. D. (2008) Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs). Biol. Chem. 389, 653-668
112. Wilson, S., Greer, B., Hooper, J., Zijlstra, A., Walker, B., Quigley, J. and Hawthorne, S. (2005) The membrane-anchored serine protease, TMPRSS2, activates PAR-2 in prostate cancer cells. Biochem. J. 388, 967-972
113. Seitz, I., Hess, S., Schulz, H., Eckl, R., Busch, G., Montens, H. P., Brandl, R., Seidl, S., Schomig, A. and Ott, I. (2007) Membrane-type serine protease-1/matriptase induces interleukin-6 and -8 in endothelial cells by activation of protease-activated receptor-2: potential implications in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 27, 769-775
114. Chokki, M., Eguchi, H., Hamamura, I., Mitsuhashi, H. and Kamimura, T. (2005) Human airway trypsin-like protease induces amphiregulin release through a mechanism involving protease-activated receptor-2-mediated ERK activation and TNFα-converting enzyme activity in airway epithelial cells. FEBS J. 272, 6387-6399
115. Chen, L. M., Hatfield, M. L., Fu, Y. Y. and Chai, K. X. (2009) Prostasin regulates iNOS and cyclin D1 expression by modulating protease-activated receptor-2 signaling in prostate epithelial cells. Prostate 69, 1790-1801
116. Nusrat, A., Parkos, C. A., Bacarra, A. E., Godowski, P. J., Delp-Archer, C., Rosen, E. M. and Madara, J. L. (1994) Hepatocyte growth factor/scatter factor effects on epithelia. Regulation of intercellular junctions in transformed and nontransformed cell lines, basolateral polarization of c-met receptor in transformed and natural intestinal epithelia, and induction of rapid wound repair in a transformed model epithelium. J. Clin. Invest. 93, 2056-2065
117. Bhatt, A. S., Welm, A., Farady, C. J., Vasquez, M., Wilson, K. and Craik, C. S. (2007) Coordinate expression and functional profiling identify an extracellular proteolytic signaling pathway. Proc. Natl. Acad. Sci. U.S.A. 104, 5771-5776
118. Sakamoto, O., Iwama, A., Amitani, R., Takehara, T., Yamaguchi, N., Yamamoto, T., Masuyama, K., Yamanaka, T., Ando, M. and Suda, T. (1997) Role of macrophage-stimulating protein and its receptor, RON tyrosine kinase, in ciliary motility. J. Clin. Invest. 99, 701-709
119. Forbs, D., Thiel, S., Stella, M. C., Sturzebecher, A., Schweinitz, A., Steinmetzer, T., Sturzebecher, J. and Uhland, K. (2005) In vitro inhibition of matriptase prevents invasive growth of cell lines of prostate and colon carcinoma. Int. J. Oncol. 27, 1061-1070
120. Lee, S. L., Huang, P. Y., Roller, P., Cho, E. G., Park, D. and Dickson, R. B. (2010) Matriptase/epithin participates in mammary epithelial cell growth and morphogenesis through HGF activation. Mech. Dev. 127, 82-95
121. Kirchhofer, D., Peek, M., Lipari, M. T., Billeci, K., Fan, B. and Moran, P. (2005) Hepsin activates pro-hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor-1B (HAI-1B) and HAI-2. FEBS Lett. 579, 1945-1950
122. Chen, M., Fu, Y. Y., Lin, C. Y., Chen, L. M. and Chai, K. X. (2007) Prostasin induces protease-dependent and independent molecular changes in the human prostate carcinoma cell line PC-3. Biochim. Biophys. Acta 1773, 1133-1140
123. Chen, M., Chen, L. M., Lin, C. Y. and Chai, K. X. (2008) The epidermal growth factor receptor (EGFR) is proteolytically modified by the matriptase-prostasin serine protease cascade in cultured epithelial cells. Biochim. Biophys. Acta 1783, 896-903
124. Chen, M., Chen, L. M., Lin, C. Y. and Chai, K. X. (2010) Hepsin activates prostasin and cleaves the extracellular domain of the epidermal growth factor receptor. Mol. Cell. Biochem. 337, 259-266
125. Darragh, M. R., Bhatt, A. S. and Craik, C. S. (2008) MT-SP1 proteolysis and regulation of cell-microenvironment interactions. Front. Biosci. 13, 528-539
126. Gladysheva, I. P., Robinson, B. R., Houng, A. K., Kovats, T. and King, S. M. (2008) Corin is co-expressed with pro-ANP and localized on the cardiomyocyte surface in both zymogen and catalytically active forms. J. Mol. Cell Cardiol. 44, 131-142
127. Yan, W., Wu, F., Morser, J. and Wu, Q. (2000) Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme. Proc. Natl. Acad. Sci. U.S.A. 97, 8525-8529
128. Wu, F., Yan, W., Pan, J., Morser, J. and Wu, Q. (2002) Processing of pro-atrial natriuretic peptide by corin in cardiac myocytes. J. Biol. Chem. 277, 16900-16905
129. Das, B. B. and Solinger, R. (2009) Role of natriuretic peptide family in cardiovascular medicine. Cardiovasc. Hematol. Agents Med. Chem. 7, 29-42
130. Lee, C. Y. and Burnett, Jr, J. C. (2007) Natriuretic peptides and therapeutic applications. Heart Fail. Rev. 12, 131-142
131. Chan, J. C., Knudson, O., Wu, F., Morser, J., Dole, W. P. and Wu, Q. (2005) Hypertension in mice lacking the proatrial natriuretic peptide convertase corin. Proc. Natl. Acad. Sci. U.S.A. 102, 785-790
132. John, S. W., Krege, J. H., Oliver, P. M., Hagaman, J. R., Hodgin, J. B., Pang, S. C., Flynn, T. G. and Smithies, O. (1995) Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 267, 679-681
133. Berger, R., Huelsman, M., Strecker, K., Bojic, A., Moser, P., Stanek, B. and Pacher, R. (2002) B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 105, 2392-2397
134. Tamura, N., Ogawa, Y., Chusho, H., Nakamura, K., Nakao, K., Suda, M., Kasahara, M., Hashimoto, R., Katsuura, G., Mukoyama, M. et al. (2000) Cardiac fibrosis in mice lacking brain natriuretic peptide. Proc. Natl. Acad. Sci. U.S.A. 97, 4239-4244
135. Rame, J. E., Tam, S. W., McNamara, D., Worcel, M., Sabolinski, M. L., Wu, A. H. and Dries, D. L. (2009) Dysfunctional corin I555(P568) allele is associated with impaired brain natriuretic peptide processing and adverse outcomes in blacks with systolic heart failure: results from the genetic risk assessment in heart failure substudy. Circ. Heart Fail. 2, 541-548
136. Vuagniaux, G., Vallet, V., Jaeger, N. F., Hummler, E. and Rossier, B. C. (2002) Synergistic activation of ENaC by three membrane-bound channel-activating serine proteases (mCAP1, mCAP2, and mCAP3) and serum- and glucocorticoid- regulated kinase (Sgk1) in Xenopus oocytes. J. Gen. Physiol. 120, 191-201
137. Kleyman, T. R., Carattino, M. D. and Hughey, R. P. (2009) ENaC at the cutting edge: regulation of epithelial sodium channels by proteases. J. Biol. Chem. 284, 20447-20451
138. Adachi, M., Kitamura, K., Miyoshi, T., Narikiyo, T., Iwashita, K., Shiraishi, N., Nonoguchi, H. and Tomita, K. (2001) Activation of epithelial sodium channels by prostasin in Xenopus oocytes. J. Am. Soc. Nephrol. 12, 1114-1121
139. Vuagniaux, G., Vallet, V., Jaeger, N. F., Pfister, C., Bens, M., Farman, N., Courtois-Coutry, N., Vandewalle, A., Rossier, B. C. and Hummler, E. (2000) Activation of the amiloride-sensitive epithelial sodium channel by the serine protease mCAP1 expressed in a mouse cortical collecting duct cell line. J. Am. Soc. Nephrol. 11, 828-834
140. Tong, Z., Illek, B., Bhagwandin, V. J., Verghese, G. M. and Caughey, G. H. (2004) Prostasin, a membrane-anchored serine peptidase, regulates sodium currents in JME/CF15 cells, a cystic fibrosis airway epithelial cell line. Am. J. Physiol. Lung Cell. Mol. Physiol. 287, L928-L935
141. + channels are fully activated by furin- and prostasin-dependent release of an inhibitory peptide from the gamma-subunit. J. Biol. Chem. 282, 6153-6160
142. Carattino, M. D., Hughey, R. P. and Kleyman, T. R. (2008) Proteolytic processing of the epithelial sodium channel gamma subunit has a dominant role in channel activation. J. Biol. Chem. 283, 25290-25295
143. + channels by low plasmin concentrations. Am. J. Physiol Regul. Integr. Comp. Physiol. 297, R1733-R1741
144. Vallet, V., Pfister, C., Loffing, J. and Rossier, B. C. (2002) Cell-surface expression of the channel activating protease xCAP-1 is required for activation of ENaC in the Xenopus oocyte. J. Am. Soc. Nephrol. 13, 588-594
145. Garcia-Caballero, A., Dang, Y., He, H. and Stutts, M. J. (2008) ENaC proteolytic regulation by channel-activating protease 2. J. Gen. Physiol. 132, 521-535
146. Donaldson, S. H., Hirsh, A., Li, D. C., Holloway, G., Chao, J., Boucher, R. C. and Gabriel, S. E. (2002) Regulation of the epithelial sodium channel by serine proteases in human airways. J. Biol. Chem. 277, 8338-8345
147. Planes, C., Randrianarison, N. H., Charles, R. P., Frateschi, S., Cluzeaud, F., Vuagniaux, G., Soler, P., Clerici, C., Rossier, B. C. and Hummler, E. (2010) ENaC-mediated alveolar fluid clearance and lung fluid balance depend on the channel-activating protease 1. EMBO Mol. Med. 2, 26-37
148. Donaldson, S. H. and Boucher, R. C. (2007) Sodium channels and cystic fibrosis. Chest 132, 1631-1636
149. Myerburg, M. M., McKenna, E. E., Luke, C. J., Frizzell, R. A., Kleyman, T. R. and Pilewski, J. M. (2008) Prostasin expression is regulated by airway surface liquid volume and is increased in cystic fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 294, L932-L941
150. Hummler, E. (1999) Implication of ENaC in salt-sensitive hypertension. J. Steroid Biochem. Mol. Biol. 69, 385-390
151. Zhu, H., Guo, D., Li, K., Yan, W., Tan, Y., Wang, X., Treiber, F. A., Chao, J., Snieder, H. and Dong, Y. (2008) Prostasin: a possible candidate gene for human hypertension. Am. J. Hypertens. 21, 1028-1033
152. Maekawa, A., Kakizoe, Y., Miyoshi, T., Wakida, N., Ko, T., Shiraishi, N., Adachi, M., Tomita, K. and Kitamura, K. (2009) Camostat mesilate inhibits prostasin activity and reduces blood pressure and renal injury in salt-sensitive hypertension. J. Hypertens. 27, 181-189
153. Silvestri, L., Pagani, A., Nai, A., De, D., I, Kaplan, J. and Camaschella, C. (2008) The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. Cell Metab. 8, 502-511
154. Finberg, K. E., Heeney, M. M., Campagna, D. R., Aydinok, Y., Pearson, H. A., Hartman, K. R., Mayo, M. M., Samuel, S. M., Strouse, J. J., Markianos, K. et al. (2008) Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). Nat. Genet. 40, 569-571
155. Guillem, F., Lawson, S., Kannengiesser, C., Westerman, M., Beaumont, C. and Grandchamp, B. (2008) Two nonsense mutations in the TMPRSS6 gene in a patient with microcytic anemia and iron deficiency. Blood 112, 2089-2091
156. Melis, M. A., Cau, M., Congiu, R., Sole, G., Barella, S., Cao, A., Westerman, M., Cazzola, M. and Galanello, R. (2008) A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron. Haematologica 93, 1473-1479
157. Folgueras, A. R., de Lara, F. M., Pendas, A. M., Garabaya, C., Rodriguez, F., Astudillo, A., Bernal, T., Cabanillas, R., Lopez-Otin, C. and Velasco, G. (2008) Membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis. Blood 112, 2539-2545
158. Truksa, J., Gelbart, T., Peng, H., Beutler, E., Beutler, B. and Lee, P. (2009) Suppression of the hepcidin-encoding gene Hamp permits iron overload in mice lacking both hemojuvelin and matriptase-2/TMPRSS6. Br. J. Haematol. 147, 571-581
159. Babitt, J. L., Huang, F. W., Xia, Y., Sidis, Y., Andrews, N. C. and Lin, H. Y. (2007) Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. J. Clin. Invest. 117, 1933-1939
160. Choi, S. Y., Bertram, S., Glowacka, I., Park, Y. W. and Pohlmann, S. (2009) Type II transmembrane serine proteases in cancer and viral infections. Trends Mol. Med. 15, 303-312
161. Kido, H., Okumura, Y., Takahashi, E., Pan, H. Y., Wang, S., Chida, J., Le, T. Q. and Yano, M. (2008) Host envelope glycoprotein processing proteases are indispensable for entry into human cells by seasonal and highly pathogenic avian influenza viruses. J. Mol. Genet. Med. 3, 167-175
162. Bottcher, E., Matrosovich, T., Beyerle, M., Klenk, H. D., Garten, W. and Matrosovich, M. (2006) Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium. J. Virol. 80, 9896-9898
163. Bottcher, E., Freuer, C., Steinmetzer, T., Klenk, H. D. and Garten, W. (2009) MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition. Vaccine 27, 6324-6329
164. Chaipan, C., Kobasa, D., Bertram, S., Glowacka, I., Steffen, I., Solomon, T. T., Takeda, M., Bugge, T., Kim, S., Park, Y., Marzi, A. and Pohlmann, S. (2009) Proteolytic activation of the 1918 influenza virus hemagglutinin. J. Virol. 83, 3200-3211
165. Shirogane, Y., Takeda, M., Iwasaki, M., Ishiguro, N., Takeuchi, H., Nakatsu, Y., Tahara, M., Kikuta, H. and Yanagi, Y. (2008) Efficient multiplication of human metapneumovirus in Vero cells expressing the transmembrane serine protease TMPRSS2. J. Virol. 82, 8942-8946
166. Zhang, J. L., Zhao, W. G., Wu, K. L., Wang, K., Zhang, X., Gu, C. F., Li, Y., Zhu, Y. and Wu, J. G. (2005) Human hepatitis B virus X protein promotes cell proliferation and inhibits cell apoptosis through interacting with a serine protease hepsin. Arch. Virol. 150, 721-741
167. Kam, Y. W., Okumura, Y., Kido, H., Ng, L. F., Bruzzone, R. and Altmeyer, R. (2009) Cleavage of the SARS coronavirus spike glycoprotein by airway proteases enhances virus entry into human bronchial epithelial cells in vitro. PLoS ONE 4, e7870
168. List, K., Haudenschild, C. C., Szabo, R., Chen, W., Wahl, S. M., Swaim, W., Engelholm, L. H., Behrendt, N. and Bugge, T. H. (2002) Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis. Oncogene 21, 3765-3779
169. List, K., Szabo, R., Wertz, P. W., Segre, J., Haudenschild, C. C., Kim, S. Y. and Bugge, T. H. (2003) Loss of proteolytically processed filaggrin caused by epidermal deletion of matriptase/MT-SP1. J. Cell Biol. 163, 901-910
170. Basel-Vanagaite, L., Attia, R., Ishida-Yamamoto, A., Rainshtein, L., Ben Amitai, D., Lurie, R., Pasmanik-Chor, M., Indelman, M., Zvulunov, A., Saban, S. et al. (2007) Autosomal recessive ichthyosis with hypotrichosis caused by a mutation in ST14, encoding type II transmembrane serine protease matriptase. Am. J. Hum. Genet. 80, 467-477
171. Avrahami, L., Maas, S., Pasmanik-Chor, M., Rainshtein, L., Magal, N., Smitt, J., van Marle, J., Shohat, M. and Basel-Vanagaite, L. (2008) Autosomal recessive ichthyosis with hypotrichosis syndrome: further delineation of the phenotype. Clin. Genet. 74, 47-53
172. List, K., Currie, B., Scharschmidt, T. C., Szabo, R., Shireman, J., Molinolo, A., Cravatt, B. F., Segre, J. and Bugge, T. H. (2007) Autosomal ichthyosis with hypotrichosis syndrome displays low matriptase proteolytic activity and is phenocopied in ST14 hypomorphic mice. J. Biol. Chem. 282, 36714-36723
173. Alef, T., Torres, S., Hausser, I., Metze, D., Tursen, U., Lestringant, G. G. and Hennies, H. C. (2009) Ichthyosis, follicular atrophoderma, and hypotrichosis caused by mutations in ST14 is associated with impaired profilaggrin processing. J. Invest. Dermatol. 129, 862-869
174. List, K., Kosa, P., Szabo, R., Bey, A. L., Wang, C. B., Molinolo, A. and Bugge, T. H. (2009) Epithelial integrity is maintained by a matriptase-dependent proteolytic pathway. Am. J. Pathol. 175, 1453-1463
175. Guipponi, M., Antonarakis, S. E. and Scott, H. S. (2008) TMPRSS3, a type II transmembrane serine protease mutated in non-syndromic autosomal recessive deafness. Front. Biosci. 13, 1557-1567
176. Scott, H. S., Kudoh, J., Wattenhofer, M., Shibuya, K., Berry, A., Chrast, R., Guipponi, M., Wang, J., Kawasaki, K., Asakawa, S. et al. (2001) Insertion of beta-satellite repeats identifies a transmembrane protease causing both congenital and childhood onset autosomal recessive deafness. Nat. Genet. 27, 59-63
177. Lee, Y. J., Park, D., Kim, S. Y. and Park, W. J. (2003) Pathogenic mutations but not polymorphisms in congenital and childhood onset autosomal recessive deafness disrupt the proteolytic activity of TMPRSS3. J. Med. Genet. 40, 629-631
178. Wattenhofer, M., Di Iorio, M. V., Rabionet, R., Dougherty, L., Pampanos, A., Schwede, T., Montserrat-Sentis, B., Arbones, L., Iliades, T., Pasquadibisceglie, A. et al. (2002) Mutations in the TMPRSS3 gene are a rare cause of childhood nonsyndromic deafness in Caucasian patients. J. Mol. Med. 80, 124-131
179. Guipponi, M., Tan, J., Cannon, P. Z., Donley, L., Crewther, P., Clarke, M., Wu, Q., Shepherd, R. K. and Scott, H. S. (2007) Mice deficient for the type II transmembrane serine protease, TMPRSS1/hepsin, exhibit profound hearing loss. Am. J. Pathol. 171, 608-616
180. Netzel-Arnett, S., Bugge, T. H., Hess, R. A., Carnes, K., Stringer, B. W., Scarman, A. L., Hooper, J. D., Tonks, I. D., Kay, G. F. and Antalis, T. M. (2009) The glycosylphosphatidylinositol-anchored serine protease PRSS21 (testisin) imparts murine epididymal sperm cell maturation and fertilizing ability. Biol. Reprod. 81, 921-932
181. Yamashita, M., Honda, A., Ogura, A., Kashiwabara, S., Fukami, K. and Baba, T. (2008) Reduced fertility of mouse epididymal sperm lacking Prss21/Tesp5 is rescued by sperm exposure to uterine microenvironment. Genes Cells 13, 1001-1013
182. Enshell-Seijffers, D., Lindon, C. and Morgan, B. A. (2008) The serine protease corin is a novel modifier of the Agouti pathway. Development 135, 217-225
183. Szabo, R., Molinolo, A., List, K. and Bugge, T. H. (2007) Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental development. Oncogene 26, 1546-1556
184. Lee, J. W., Yong, S. S., Choi, J. J., Lee, S. J., Kim, B. G., Park, C. S., Lee, J. H., Lin, C. Y., Dickson, R. B. and Bae, D. S. (2005) Increased expression of matriptase is associated with histopathologic grades of cervical neoplasia. Hum. Pathol. 36, 626-633
185. List, K., Szabo, R., Molinolo, A., Sriuranpong, V., Redeye, V., Murdock, T., Burke, B., Nielsen, B. S., Gutkind, J. S. and Bugge, T. H. (2005) Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation. Genes Dev. 19, 1934-1950
186. Ihara, S., Miyoshi, E., Ko, J. H., Murata, K., Nakahara, S., Honke, K., Dickson, R. B., Lin, C. Y. and Taniguchi, N. (2002) Prometastatic effect of N-acetylglucosaminyltransferase V is due to modification and stabilization of active matriptase by adding β1-6 GlcNAc branching. J. Biol. Chem. 277, 16960-16967
187. Jung, H., Lee, K. P., Park, S. J., Park, J. H., Jang, Y. S., Choi, S. Y., Jung, J. G., Jo, K., Park, D. Y., Yoon, J. H. et al. (2008) TMPRSS4 promotes invasion, migration and metastasis of human tumor cells by facilitating an epithelial-mesenchymal transition. Oncogene 27, 2635-2647
188. Tomlins, S. A., Laxman, B., Dhanasekaran, S. M., Helgeson, B. E., Cao, X., Morris, D. S., Menon, A., Jing, X., Cao, Q., Han, B. et al. (2007) Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature 448, 595-599
189. Nam, R. K., Sugar, L., Yang, W., Srivastava, S., Klotz, L. H., Yang, L. Y., Stanimirovic, A., Encioiu, E., Neill, M., Loblaw, D. A. et al. (2007) Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer. Br. J. Cancer 97, 1690-1695 (Pubitemid 350249347)
190. Sanders, A. J., Parr, C., Martin, T. A., Lane, J., Mason, M. D. and Jiang, W. G. (2008) Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitroand in vivoand affects FAK and paxillin localisation. J. Cell Physiol. 216, 780-789
191. Parr, C., Sanders, A. J., Davies, G., Martin, T., Lane, J., Mason, M. D., Mansel, R. E. and Jiang, W. G. (2007) Matriptase-2 inhibits breast tumor growth and invasion and correlates with favorable prognosis for breast cancer patients. Clin. Cancer Res. 13, 3568-3576
192. Lang, J. C. and Schuller, D. E. (2001) Differential expression of a novel serine protease homologue in squamous cell carcinoma of the head and neck. Br. J. Cancer 84, 237-243
193. Sakashita, K., Mimori, K., Tanaka, F., Tahara, K., Inoue, H., Sawada, T., Ohira, M., Hirakawa, K. and Mori, M. (2008) Clinical significance of low expression of prostasin mRNA in human gastric cancer. J. Surg. Oncol. 98, 559-564
194. Tang, T., Kmet, M., Corral, L., Vartanian, S., Tobler, A. and Papkoff, J. (2005) Testisin, a glycosyl-phosphatidylinositol-linked serine protease, promotes malignant transformation in vitroand in vivo. Cancer Res. 65, 868-878 (Pubitemid 40216446)
195. Manton, K. J., Douglas, M. L., Netzel-Arnett, S., Fitzpatrick, D. R., Nicol, D. L., Boyd, A. W., Clements, J. A. and Antalis, T. M. (2005) Hypermethylation of the 5′ CpG island of the gene encoding the serine protease testisin promotes its loss in testicular tumorigenesis. Br. J. Cancer 92, 760-769
196. Kempkensteffen, C., Christoph, F., Weikert, S., Krause, H., Kollermann, J., Schostak, M., Miller, K. and Schrader, M. (2006) Epigenetic silencing of the putative tumor suppressor gene testisin in testicular germ cell tumors. J. Cancer Res. Clin. Oncol. 132, 765-770
197. Shigemasa, K., Underwood, L. J., Beard, J., Tanimoto, H., Ohama, K., Parmley, T. H. and O'Brien, T. J. (2000) Overexpression of testisin, a serine protease expressed by testicular germ cells, in epithelial ovarian tumor cells. J. Soc. Gynecol. Invest. 7, 358-362
198. Tripathi, M., Nandana, S., Yamashita, H., Ganesan, R., Kirchhofer, D. and Quaranta, V. (2008) Laminin-332 is a substrate for hepsin, a protease associated with prostate cancer progression. J. Biol. Chem. 283, 30576-30584
199. Silverman, G. A., Bird, P. I., Carrell, R. W., Church, F. C., Coughlin, P. B., Gettins, P. G., Irving, J. A., Lomas, D. A., Luke, C. J., Moyer, R. W. et al. (2001) The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J. Biol. Chem. 276, 33293-33296
200. Gettins, P. G. (2002) Serpin structure, mechanism, and function. Chem. Rev. 102, 4751-4804
201. Herz, J. and Strickland, D. K. (2001) LRP: a multifunctional scavenger and signaling receptor. J. Clin. Invest 108, 779-784
202. Tseng, I. C., Chou, F. P., Su, S. F., Oberst, M., Madayiputhiya, N., Lee, M. S., Wang, J. K., Sloane, D. E., Johnson, M. and Lin, C. Y. (2008) Purification from human milk of matriptase complexes with secreted serpins: mechanism for inhibition of matriptase other than HAI-1. Am. J. Physiol. Cell Physiol. 295, C423-C431
203. Szabo, R., Netzel-Arnett, S., Hobson, J. P., Antalis, T. M. and Bugge, T. H. (2005) Matriptase-3 is a novel phylogenetically preserved membrane-anchored serine protease with broad serpin reactivity. Biochem. J. 390, 231-242
204. Wakida, N., Kitamura, K., Tuyen, D. G., Maekawa, A., Miyoshi, T., Adachi, M., Shiraishi, N., Ko, T., Ha, V., Nonoguchi, H. and Tomita, K. (2006) Inhibition of prostasin-induced ENaC activities by PN-1 and regulation of PN-1 expression by TGF-β1 and aldosterone. Kidney Int. 70, 1432-1438
205. Fan, B., Wu, T. D., Li, W. and Kirchhofer, D. (2005) Identification of hepatocyte growth factor activator inhibitor-1B as a potential physiological inhibitor of prostasin. J. Biol. Chem. 280, 34513-34520
206. Lin, C. Y., Anders, J., Johnson, M., Sang, Q. A. and Dickson, R. B. (1999) Molecular cloning of cDNA for matriptase, a matrix-degrading serine protease with trypsin-like activity. J. Biol. Chem. 274, 18231-18236
207. Oberst, M. D., Chen, L. Y., Kiyomiya, K., Williams, C. A., Lee, M. S., Johnson, M. D., Dickson, R. B. and Lin, C. Y. (2005) HAI-1 regulates activation and expression of matriptase, a membrane-bound serine protease. Am. J. Physiol. Cell Physiol. 289, C462-C470
208. Kojima, K., Tsuzuki, S., Fushiki, T. and Inouye, K. (2008) Roles of functional and structural domains of hepatocyte growth factor activator inhibitor type 1 in the inhibition of matriptase. J. Biol. Chem. 283, 2478-2487
209. Szabo, R., Kosa, P., List, K. and Bugge, T. H. (2009) Loss of matriptase suppression underlies spint1 mutation-associated ichthyosis and postnatal lethality. Am. J. Pathol. 174, 2015-2022
210. Nagaike, K., Kawaguchi, M., Takeda, N., Fukushima, T., Sawaguchi, A., Kohama, K., Setoyama, M. and Kataoka, H. (2008) Defect of hepatocyte growth factor activator inhibitor type 1/serine protease inhibitor, Kunitz type 1 (Hai-1/Spint1) leads to ichthyosis-like condition and abnormal hair development in mice. Am. J. Pathol. 173, 1464-1475
211. Szabo, R., Hobson, J. P., List, K., Molinolo, A., Lin, C. Y. and Bugge, T. H. (2008) Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity. J. Biol. Chem. 283, 29495-29504
212. Coote, K., Atherton-Watson, H. C., Sugar, R., Young, A., MacKenzie-Beevor, A., Gosling, M., Bhalay, G., Bloomfield, G., Dunstan, A., Bridges, R. J. et al. (2009) Camostat attenuates airway epithelial sodium channel function in vivo through the inhibition of a channel-activating protease. J. Pharmacol. Exp. Ther. 329, 764-774
213. Szabo, R., Hobson, J. P., Christoph, K., Kosa, P., List, K. and Bugge, T. H. (2009) Regulation of cell surface protease matriptase by HAI2 is essential for placental development, neural tube closure and embryonic survival in mice. Development 136, 2653-2663
214. Zhukov, A., Hellman, U. and Ingelman-Sundberg, M. (1997) Purification and characterization of hepsin from rat liver microsomes. Biochim. Biophys. Acta 1337, 85-95
215. Stoop, A. A. and Craik, C. S. (2003) Engineering of a macromolecular scaffold to develop specific protease inhibitors. Nat. Biotechnol. 21, 1063-1068
216. Katz, B. A., Luong, C., Ho, J. D., Somoza, J. R., Gjerstad, E., Tang, J., Williams, S. R., Verner, E., Mackman, R. L., Young, W. B. et al. (2004) Dissecting and designing inhibitor selectivity determinants at the S1 site using an artificial Ala190 protease (Ala190 uPA). J. Mol. Biol. 344, 527-547
217. Yuan, J., Beltman, J., Gjerstad, E., Nguyen, M. T., Sampang, J., Chan, H., Janc, J. W. and Clark, J. M. (2006) Expression and characterization of recombinant gamma-tryptase. Protein Expression Purif. 49, 47-54
218. Galkin, A. V., Mullen, L., Fox, W. D., Brown, J., Duncan, D., Moreno, O., Madison, E. L. and Agus, D. B. (2004) CVS-3983, a selective matriptase inhibitor, suppresses the growth of androgen independent prostate tumor xenografts. Prostate 61, 228-235
219. Steinmetzer, T., Schweinitz, A., Sturzebecher, A., Donnecke, D., Uhland, K., Schuster, O., Steinmetzer, P., Muller, F., Friedrich, R., Than, M. E. et al. (2006) Secondary amides of sulfonylated 3-amidinophenylalanine. New potent and selective inhibitors of matriptase. J. Med. Chem. 49, 4116-4126
220. Yamaguchi, N., Okui, A., Yamada, T., Nakazato, H. and Mitsui, S. (2002) Spinesin/TMPRSS5, a novel transmembrane serine protease, cloned from human spinal cord. J. Biol. Chem. 277, 6806-6812
221. Knecht, W., Cottrell, G. S., Amadesi, S., Mohlin, J., Skaregarde, A., Gedda, K., Peterson, A., Chapman, K., Hollenberg, M. D., Vergnolle, N. and Bunnett, N. W. (2007) Trypsin IV or mesotrypsin and p23 cleave protease-activated receptors 1 and 2 to induce inflammation and hyperalgesia. J. Biol. Chem. 282, 26089-26100
222. Kunitz, M. (1939) Formation of trypsin from crystalline trypsinogen by means of enterokinase. J. Gen. Physiol. 22, 429-446
223. 4-Lys-Ile-Val-Gly and its analogs. Biosci. Biotechnol. Biochem. 72, 905-908
224. Kang, J. Y., Dolled-Filhart, M., Ocal, I. T., Singh, B., Lin, C. Y., Dickson, R. B., Rimm, D. L. and Camp, R. L. (2003) Tissue microarray analysis of hepatocyte growth factor/Met pathway components reveals a role for Met, matriptase, and hepatocyte growth factor activator inhibitor 1 in the progression of node-negative breast cancer. Cancer Res. 63, 1101-1105
225. Parr, C., Watkins, G., Mansel, R. E. and Jiang, W. G. (2004) The hepatocyte growth factor regulatory factors in human breast cancer. Clin. Cancer Res. 10, 202-211
226. Bhatt, A. S., Erdjument-Bromage, H., Tempst, P., Craik, C. S. and Moasser, M. M. (2005) Adhesion signaling by a novel mitotic substrate of src kinases. Oncogene 24, 5333-5343
227. Ahmed, S., Jin, X., Yagi, M., Yasuda, C., Sato, Y., Higashi, S., Lin, C. Y., Dickson, R. B. and Miyazaki, K. (2006) Identification of membrane-bound serine proteinase matriptase as processing enzyme of insulin-like growth factor binding protein-related protein-1 (IGFBP-rP1/angiomodulin/mac25). FEBS J. 273, 615-627
228. Knappe, S., Wu, F., Masikat, M. R., Morser, J. and Wu, Q. (2003) Functional analysis of the transmembrane domain and activation cleavage of human corin: design and characterization of a soluble corin. J. Biol. Chem. 278, 52363-52370
229. Leyvraz, C., Charles, R. P., Rubera, I., Guitard, M., Rotman, S., Breiden, B., Sandhoff, K. and Hummler, E. (2005) The epidermal barrier function is dependent on the serine protease CAP1/Prss8. J. Cell Biol. 170, 487-496
230. Klezovitch, O., Chevillet, J., Mirosevich, J., Roberts, R. L., Matusik, R. J. and Vasioukhin, V. (2004) Hepsin promotes prostate cancer progression and metastasis. Cancer Cell 6, 185-195
231. Kim, T. S., Heinlein, C., Hackman, R. C. and Nelson, P. S. (2006) Phenotypic analysis of mice lacking the Tmprss2-encoded protease. Mol. Cell. Biol. 26, 965-975
232. List, K., Szabo, R., Molinolo, A., Nielsen, B. S. and Bugge, T. H. (2006) Delineation of matriptase protein expression by enzymatic gene trapping suggests diverging roles in barrier function, hair formation, and squamous cell carcinogenesis. Am. J. Pathol. 168, 1513-1525
233. Du, X., She, E., Gelbart, T., Truksa, J., Lee, P., Xia, Y., Khovananth, K., Mudd, S., Mann, N., Moresco, E. M. et al. (2008) The serine protease TMPRSS6 is required to sense iron deficiency. Science 320, 1088-1092 (Pubitemid 351929552)
234. Chen, L. M., Zhang, X. and Chai, K. X. (2004) Regulation of prostasin expression and function in the prostate. Prostate 59, 1-12
235. Viloria, C. G., Peinado, J. R., Astudillo, A., Garcia-Suarez, O., Gonzalez, M. V., Suarez, C. and Cal, S. (2007) Human DESC1 serine protease confers tumorigenic properties to MDCK cells and it is upregulated in tumours of different origin. Br. J. Cancer 97, 201-209
236. Gasparian, M. E., Ostapchenko, V. G., Dolgikh, D. A. and Kirpichnikov, M. P. (2006) Biochemical characterization of human enteropeptidase light chain. Biochemistry (Moscow) 71, 113-119
237. Liepnieks, J. J. and Light, A. (1979) The preparation and properties of bovine enterokinase. J. Biol. Chem. 254, 1677-1683
238. Janciauskiene, S., Nita, I., Subramaniyam, D., Li, Q., Lancaster, Jr, J. R. and Matalon, S. (2008) α1-antitrypsin inhibits the activity of the matriptase catalytic domain in vitro. Am. J. Respir. Cell Mol. Biol. 39, 631-637
239. Kirchhofer, D., Peek, M., Li, W., Stamos, J., Eigenbrot, C., Kadkhodayan, S., Elliott, J. M., Corpuz, R. T., Lazarus, R. A. and Moran, P. (2003) Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1. J. Biol. Chem. 278, 36341-36349
240. Yamasaki, Y., Satomi, S., Murai, N., Tsuzuki, S. and Fushiki, T. (2003) Inhibition of membrane-type serine protease 1/matriptase by natural and synthetic protease inhibitors. J. Nutr. Sci. Vitaminol. (Tokyo) 49, 27-32